Long-Term Adherence to Evidence Based Secondary Prevention Therapies after Acute Myocardial Infarction

被引:0
|
作者
Ayse Akincigil
John R. Bowblis
Carrie Levin
Saira Jan
Minalkumar Patel
Stephen Crystal
机构
[1] Rutgers,School of Social Work
[2] The State University of New Jersey,Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, Institute for Health, Health Care Policy and Aging Research
[3] Rutgers,Ernest Mario School of Pharmacy
[4] The State University of New Jersey,undefined
[5] Rutgers University,undefined
[6] Horizon Blue Cross Blue Shield of New Jersey,undefined
[7] Horizon Healthcare Insurance Company of New York,undefined
来源
Journal of General Internal Medicine | 2008年 / 23卷
关键词
acute myocardial infarction; adherence; beta-blockers; angiotensin converting enzyme inhibitors (ACEI); secondary prevention;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:115 / 121
页数:6
相关论文
共 50 条
  • [11] Role of psychosocial factors in long-term adherence to secondary prevention measures after myocardial infarction: a longitudinal analysis
    Nachshol, Michal
    Lurie, Ido
    Benyamini, Yael
    Goldbourt, Uri
    Gerber, Yariv
    ANNALS OF EPIDEMIOLOGY, 2020, 52 : 35 - 41
  • [12] SECONDARY PREVENTION AFTER MYOCARDIAL-INFARCTION - A REVIEW OF LONG-TERM TRIALS
    MAY, GS
    EBERLEIN, KA
    FURBERG, CD
    PASSAMANI, ER
    DEMETS, DL
    PROGRESS IN CARDIOVASCULAR DISEASES, 1982, 24 (04) : 331 - 352
  • [13] 2022 Summary of recommendations for long-term secondary prevention after myocardial infarction
    Ostadal, Petr
    Taborsky, Milos
    Linhart, Ales
    Vrablik, Michal
    Ceska, Richard
    Cifkova, Renata
    Kralikova, Eva
    Adamkova, Vera
    Praznyd, Martin
    Jojko, Zorjan
    COR ET VASA, 2022, 64
  • [14] Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction
    Solomon, Matthew D.
    Leong, Thomas K.
    Sung, Sue Hee
    Jaffe, Marc
    Levin, Eleanor
    Rana, Jamal S.
    Go, Alan S.
    CIRCULATION, 2017, 136
  • [15] Association between Adherence to Secondary Prevention Therapies and Mortality in Acute Myocardial Infarction (AMI)
    Liu, Tzu-Chi
    Yang, Yea-Huei Kao
    Cheng, Ching-Lan
    Lee, Cheng-Han
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 216 - 217
  • [16] Long-Term Effects of an Intensive Prevention Program After Acute Myocardial Infarction
    Osteresch, Rico
    Fach, Andreas
    Frielitz, Fabian-Simon
    Meyer, Sven
    Schmucker, Johannes
    Ruehle, Stephan
    Retzlaff, Tina
    Hadwiger, Moritz
    Haerle, Tobias
    Elsaesser, Albrecht
    Katalinic, Alexander
    Eitel, Ingo
    Hambrecht, Rainer
    Wienbergen, Harm
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 154 : 7 - 13
  • [17] Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction
    Solomon, Matthew D.
    Leong, Thomas K.
    Levin, Eleanor
    Rana, Jamal S.
    Jaffe, Marc G.
    Sidney, Stephen
    Sung, Sue Hee
    Lee, Catherine
    DeMaria, Anthony
    Go, Alan S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (06):
  • [18] Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction
    Perrone, Enrica
    Lenzi, Jacopo
    Avaldi, Vera Maria
    Castaldini, Ilaria
    Protonotari, Adalgisa
    Rucci, Paola
    Piccinni, Carlo
    Morini, Mara
    Fantini, Maria Pia
    EPIDEMIOLOGIA & PREVENZIONE, 2015, 39 (02): : 106 - 114
  • [19] Current therapies for secondary prevention after myocardial infarction
    Cannon, CE
    Smith, SC
    CURRENT OPINION IN CARDIOLOGY, 1999, 14 (02) : 155 - 160
  • [20] LONG-TERM ANTICOAGULANTS AFTER ACUTE MYOCARDIAL INFARCTION
    不详
    LANCET, 1970, 1 (7640): : 226 - &